©The Author(s) 2025.
World J Gastrointest Oncol. Oct 15, 2025; 17(10): 110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Published online Oct 15, 2025. doi: 10.4251/wjgo.v17.i10.110203
Table 3 Tumor grade by disease stage, tumor size, and node classification, n (%)
| Variables | Grade 1, 27 (51.9) | Grade 2, 25 (48.1) | P value |
| Disease stage | |||
| Localized | 25 (92.6) | 4 (16.0) | |
| Advanced | 2 (7.4) | 21 (84.0) | < 0.001 |
| Tumor size in cm | |||
| ≤ 2 | 25 (92.6) | 6 (24.0) | |
| > 2 | 2 (7.4) | 19 (76.0) | < 0.001 |
| Classification N | |||
| N1 | 3 (11.1) | 18 (72.0) | |
| N0 | 24 (88.9) | 7 (28.0) | < 0.001 |
- Citation: Cruz-Diaz WE, Leonardo A, Saavedra A, Paitan V, Haro-Varas J, Mantilla R, Macetas J, Veramendi E, Pacheco C, Calderón M, Vidaurre T, Castro-Oliden V. Rectal neuroendocrine tumors in a Latin American population: Insights from a Peruvian national cancer institute. World J Gastrointest Oncol 2025; 17(10): 110203
- URL: https://www.wjgnet.com/1948-5204/full/v17/i10/110203.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i10.110203